Arvaya Healthcare (BOM:524723) Tariff Resilience Score: 0/10 (As of Aug. 08, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524723 Arvaya Healthcare Ltd BOM:524723
36 GF Score
Price ₹119.05
GF Value ₹49.94
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Arvaya Healthcare Tariff Resilience Score?

Arvaya Healthcare has the Tariff Resilience Score of 0, which implies that the company might have .

Arvaya Healthcare has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Arvaya Healthcare might have .


Arvaya Healthcare  (BOM:524723) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Arvaya Healthcare Tariff Resilience Score Related Terms

BOM:524723
36GF Score
Arvaya Healthcare Ltd BOM:524723
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Arvaya Healthcare (BOM:524723) Overvalued in 2026?

Based on GuruFocus' analysis, Arvaya Healthcare stock appears to be overvalued. The current stock price of ₹119.05 is trading 138.4% above its estimated GF Value™ of ₹49.94. GuruFocus considers Arvaya Healthcare to be Significantly Overvalued.

Key valuation signals for BOM:524723:

  • Tariff Resilience Score: 0
  • GF Value™: ₹49.94 vs. price of ₹119.05 (138.4% above fair value)
  • GF Score™: 36/100 with 5 warning signs

No single metric tells the full story. See the BOM:524723 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Arvaya Healthcare Business Description

Address G S Road, Nirvana Co Working spaces, Mezzanine Floor, Itag Plaza, ABC, Kamrup, Dispur, Gmc, Guwahati, AS, IND, 781005
Arvaya Healthcare Ltd is focused on developing an integrated healthcare platform in India that combines hospital services, diagnostics, wellness services, and digital health management solutions. Its operations include multi-specialty hospitals, a digital health platform for appointment booking and health record management, diagnostic services including laboratory testing and home sample collection, and wellness facilities offering preventive and recovery-focused programs.
36GF Score

Get the complete analysis for BOM:524723

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹119.05
Price
₹49.94
GF Value